Soy peptide dietary supplementation increases serum dopamine level and improves cognitive dysfunction in subjects with mild cognitive impairment

Japanese Pharmacology and Therapeutics

Volumn 41, Issue 1, 2013, Pages 67-73

  Maebuchi, Motohiro ^a   Kishi, Yutaka ^b   Koikeda, Takashi ^c   Furuya, Shigeki ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b Yutaka Clinic 3   (Japan)

^c Shiba Palace Clinic   (Japan)

Author keywords

Alzheimer's disease; Brain function; Cognitive dysfunction; Dementia; Dopamine; Neuropsychological assessment; Neurotransmitter; RBANS; Soy peptide

Indexed keywords

DOPAMINE; HINUTE; PLACEBO; SOYBEAN PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BRAIN FUNCTION; CLINICAL ARTICLE; CONTROLLED STUDY; DIET SUPPLEMENTATION; DOPAMINE BLOOD LEVEL; DRUG EFFICACY; FEMALE; HUMAN; MALE; MEMORY; MILD COGNITIVE IMPAIRMENT; NEUROPSYCHOLOGICAL TEST; SCORING SYSTEM; SOYBEAN; TREATMENT RESPONSE;

EID: 84874269236     PISSN: 03863603     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Wang W, de Mejia EG. A new frontier in soy bioactive peptides that may prevent age-related chronic diseases. CRFSFS 2005 ; 4 : 63-78.
2. Martinez-Villaluenga C, Dia VP, Berhow M, Bringe NA, Gonzalez de Mejia E. Protein hydrolysates from fi-conglycinin enriched soybean genotypes inhibit lipid accumulation and inflammation in vitro. Mol Nutr Food Res 2009 ; 53 : 1007-18.
3. Nagarajan S, Burris RL, Stewart BW, Wilkerson JE, Badger TM. Dietary soy protein isolate ameliorates atherosclerotic lesions in apolipoprotein E-deficient mice potentially by inhibiting monocyte chemoattractant protein-1 expression. J Nutr 2008 I 138 : 332-7.
4. Maebuchi M, Samoto M, Kohno M, Ito R, Koileda T, Hirotsuka M, et al. Improvement in the intestinal absorption of soy protein by enzymatic digestion to oligopeptide in healthy adult men. Food Sci Technol Res 2007 I 13 : 45-53.
5. Masuda K, Maebuchi M, Samoto M, Ushijima Y, Uchida Y, Kohno M, et al. Effect of soy-peptide intake on exercise-induced muscle damage. Jap J Clin Sports Med 2007 I 15 : 228-35.
6. Nakanishi Y, Shirakawa S, Maebuchi M, Okubo M, Ikeda T, Inage H, et al. Effects of soy protein intake in peptide form on delayed-onset muscle soreness induced by eccentric exercise. J Sport Sci and Osteo Thera 2011 I 13 : 9-19.
7. Esaki K, Kokido T, Ohomoro T, Tsukino M, Ohshima T, Furuya S. Soy peptide ingestion increases neuroactive amino acids in the adult brain of wild-type and genetically engineered serine-deficient mice. J Nutr Food Sci 2011 ; 1 : 109. doi: 10.4172/2155-9600.1000109
8. Maebuchi M, Yamaguchi N, Furuya S. Soy peptide as functional food component. Med Bio 2011 I 155 : 566-76.
9. Chertkow H. Diagnosis and treatment of dementia : introduction. Introducing a series based on the Third Canadian Consensus Conference on the Diagnosis and Treatment of Dementia. CMAJ 2008 ; 178 : 316-21.
10. Yamashima T, Yoshida M, Kumahashi K, Matsui M, Koshino Y, Higashima M, et al. The Japanese version of RBANS (Repeatable Battery for the Assessment of Neuropsychological Status). No To Shinkei 2002 ; 54 : 463-71.
11. Rosenberg PB. Clinical aspects of inflammation in Alzheimer's disease. Int Rev Psychiatry 2005 I 17 : 503-14.
12. Terada T, Nakashima M, Yamasaki K, Hanano T, Yamashima T. Improvement of cognitive function by a-lipoic acid, Ginkgo Biloba extract and L-carnitine supplementation. Jpn J Compl Alternative Med 2008 : 5 : 135-43.
13. Nieoullon A. Dopamine and the regulation of cognition and attention. Prog Neurobiol 2002 I 67 : 53-83.
14. Cools R, Robbins TW. Chemistry of the adaptive mind. Phil Trans R Soc Lond A 2004 I 362 : 2871-88.
15. Elliott R, Sahakian BJ, Matthews K, Bannerjea A, Rimmer J, Robbins TW. Effects of methylphenidate on spatial working memory and planning in healthy young adults. Psychopharmacology (Berl) 1997 ; 131 : 196-206.
16. Luciana M, Collins PF. Dopaminergic modulation of working memory for spatial but not object cues in normal humans. J Cogn Neurosci 1997 I 9 : 330-47.
17. Luciana M, Depue RA, Arbisi P, Leon A. Facilitation of working memory in humans by a D2 dopamine receptor agonist. J Cogn Neurosci 1992 I 4 : 58-68.
18. Mehta MA, Sahakian BJ, McKenna PJ, Robbins TW. Systemic sulpiride in young adult volunteers simulates the profile of cognitive deficits in Parkinson's disease. Psychopharmacology (Berl) 1999 I 146 : 162-74.
19. Lehnert H, Reinstein DK, Strowbridge BW, Wurtman RJ. Neurochemical and behavioral consequences of acute, uncontrollable stress : effects of dietary tyrosine. Brain Res 1984 I 303 : 215-23.
20. Brady K, Brown JW, Thurmond JB. Behavioral and neurochemical effects of dietary tyrosine in young and aged mice following cold-swim stress. Pharmacol Biochem Behav 1980 I 12 667-74.
21. Yeghiayan SK, Luo S, Shukitt-Hale B, Lieberman HR. Tyrosine improves behavioral and neurochemical deficits caused by cold exposure. Physiol Behav 2001 ; 72 : 311-6.
22. Fitzpatrick AL, Kuller LH, Ives DG, Lopez OL, Jagust W Breitner JC, et al. Incidence and prevalence of dementia in the Cardiovascular Health Study. J Am Geriatr Soc 2004 ; 52 : 195-204.
23. Minino AM, Arias E, Kochanek KD, Murphy SL, Smith BL. Deaths : final data for 2000. Natl Vital Stat Rep 2002 ; 50 : 1-119.
24. Veld BA in't, Ruitenberg A, Hofman A, Launer LJ, van Duijn CM, Stijnen T, et al. Nonsteroidal antiinflammatory drugs and the risk of Alzheimer's disease. N Engl J Med 2001 I 345 : 1515-21.
25. Etminan M, Gill S, Samii A. Effect of non-steroidal anti-inflammatory drugs on risk of Alzheimer's disease : systematic review and meta-analysis of observational studies. BMJ 2003 ; 327 : 128-31.